Re: Help Is Here!!!One Min. That is explaining NO. But now is a explaination on L-
Arginine.
A Report On Arginine
By Harry Elwardt, N.D., PhD.
"=2E.. A few grams of prevention is worth a ton of cure." 1
So just what is Nitric Oxide (NO)? Over 20,000 articles in the medical
literature since 1980 attest that "absolutely everything in the body
depends
on it." Its function in human physiology is so important that the
American
Academy of Science named Nitric Oxide the "Molecule of the year" in
1992. The Nobel Peace prize in Medicine was awarded to scientists who
began the research on Nitric Oxide in 1998 and now NO has been
referred
to as "The Molecule of the Millennium". Dr. Jonathan S. Stamler, a
professor of medicine at Duke University Medical Center, put it best
when
he said of Nitric Oxide:
"It does everything, everywhere. You cannot name a major cellular
response or
physiological effect in which [Nitric Oxide] is not implicated today.
It's involved in
complex behavioral changes in the brain, airway relaxation, beating of
the heart,
dilation of blood vessels, regulation of intestinal movement, function
of blood
cells, the immune system, even how fingers and arms move."
There are three types of NO. Endothelial-derived NO diffuses out of
endothelial cells
(cells lining arteries and veins) and into smooth muscle cells of
arteries enhancing
relaxation and other properties of vascular physiology.
Endothelial-derived NO also functions in platelets (blood cells
responsible for blood clots)
to inhibit aggregation or blood clotting. Brain-derived NO affects
several types of nerve
cells and appears to be important in neurotransmitter pathways in both
the central as well
as peripheral nervous system and regulates the production and release
of many
hormones. Macrophage-derived NO is important in the immune system.
This type of NO
helps macrophages (a type of immune cell) kill bacteria and tumor
cells. So, NO is
important to the nervous system, the immune system and the vascular
system, which
supplies nutrients to all parts of the body. Arginine, when combined
with Oxygen, forms
NO. Arginine, as found in Ark1=99 is the source of all forms of NO.2, 3
NO decreases with age 4, 5, 6, various age related conditions and many
medications7,8.
Among the most common disease states to affect NO and therefore sexual
function are:
=B7 Diabetes
=B7 Heart disease
=B7 Hypertension (high blood pressure)
=B7 Peripheral Vascular Disease
=B7 Neurological Damage
=B7 Peptic Ulcer
=B7 Arthritis
=B7 Allergy
=B7 Low HDL
2
=B7 Some of the most common drugs affecting NO and/or sexual functions
are
antidepressants - many common drugs like Elavil=AE, Prozac=AE. Paxil=AE,
Zoloft=AE, etc.
=B7 Anti-anxiety drugs, including Xanax=AE and Valium=AE
=B7 Anti-psychotic drugs
=B7 Blood Pressure medications
=B7 Other Cardiac drugs, like lanoxin or other drugs that affect cardiac
rhythm
=B7 Anti-heartburn drugs like Tagamet=AE and Zantac=AE
=B7 Opioids especially chronic use of legal (e.g., Lortab=AE, codeine,
etc.) and illegal
(e.g., heroin) narcotics and pain medicines
=B7 Alcohol, especially chronic use
=B7 Tobacco
The use of many of these drugs and the incidence of most of this
disease conditions
increase after the age of 40. Obviously it is also the age group most
likely to benefit from
the use of Ark1=99, though any age group can benefit. The 40 and above
age group is
also the most likely age group (both men and women) to want to use
Ark1=99 for the
treatment of sexual dysfunction. In the genital tissue, NO triggers
the release of c-GMP,
which is a molecule that causes engorgement of this tissue. The
arginine found in Ark1=99
releases NO to make sure there is plenty of c-GMP. Viagra, on the
other hand, is a drug
that blocks an enzyme to make sure there is plenty of c-GMP. Arginine
has been shown
to be a safe and effective alternative to Viagra=AE. Viagra=AE has been
reported to be safe;
however, the FDA public records suggest the opposite. These records
reported that
between April of 1998 and May of 1999 there were 1,473 adverse events
including 255
serious heart rhythm disturbances, 53 episodes of congestive heart
failure (weakened
heart) 119 strokes, 517 heart attacks and 522 deaths.9
Every major disease process today is directly or indirectly related to
lack of NO.
Diabetes, Hypertension, Hyperlipidemia, Hypercholesterolemia, Cancer,
Peripheral
Vascular Disease, Coronary Artery Disease, Sickle Cell, Scleroderma,
Renal
Failure, Pulmonary Hypertension and Atherosclerosis are all associated
with
decreased levels of NO. (With the exception of cancer, where NO
functions in the
immune system, most of these disease processes involve the vascular
system and
endothelial derived NO).
The primary function of endothelial derived NO is vascular
homeostasis, or balance. NO
maintains vascular health by enhancing endothelial reactivity. The
endothelium is the
inner lining of the blood vessels and as long as the endothelium
remains reactive, they
are supple, pliable and flexible. They are able to respond
appropriately to the various
changes that occur in blood vessels in the course of normal and
abnormal physiology,
when NO decreases, the vessels become stiff and rigid.
This is called atherosclerosis or hardening of the arteries. When we
develop
atherosclerosis, the results are high blood pressure, heart attack and
stroke and
ultimately death. As long as we have plenty of NO, as can be supplied
by the arginine in
Ark1=99, our blood pressure remains low and we have protection from many
of the
consequences of the aging process.
To date arginine has been shown in animal as well as human trials that
it may be
effective in the following:
3
=B7 Decreasing and reversing atherosclerosis by decreasing intimal
thickening and
monocyte accumulation 9,10,11,12,13,14
=B7 Restore normal endothelial function in hypercholesterolemia
14,15,16,17,18,19,20,21
=B7 Reversing consequences of coronary artery disease
22,23,24,25,26,27,28,29,30
=B7 Decreasing cholesterol and triglycerides 32
=B7 Improves walking distance in peripheral vascular disease
31,33,34,35,36
=B7 Improves pain in interstitial cystitis 37,38
=B7 Prolonged administration of arginine reverses adverse effects of
high blood
pressure 39,40,41,42
=B7 Decreases high blood pressure 43
=B7 Decreases post operative infection and length of stay 44
=B7 Increases human growth hormone 45,46,47,48,49,50,116
=B7 Improves outcome after bypass surgery 51
=B7 Improves sexual function 52
=B7 Improves exercise tolerance 53,54
=B7 Improves renal function 55,56,57,58,59,60
=B7 Improves glucose uptake in muscle cells 61
=B7 Improves asthma 61,62,63,64,65,66
=B7 Improves cell mediated immunity 67,68,69,70,71
=B7 Improves pituitary responsiveness and modulates hormonal control
72,73,74
=B7 Improves muscle performance 75
=B7 Improves diabetes and reverses damage 76,77,78,79
=B7 May prevent diabetes 78
=B7 Reduces blood clots and strokes 80,81,82
=B7 Helps prevent restenosis after angioplasty and bypass 83,84,85
=B7 Helps prevent post surgical damage after intestinal manipulation 86
=B7 May improve irritable bowel syndrome 87
=B7 Improves osteoporosis 88
=B7 May improve prostate function 89
=B7 May give protection against size of heart attack 90
=B7 Helps protect in cardiac transplants 91,92
=B7 Improve scleroderma 93
=B7 Improve sickle cell disease 94
=B7 Prevent pre-eclampsia 95
=B7 Improves exercise capacity in pulmonary hypertension 96,117,118
=B7 Improves wound healing 97,98,99
=B7 Reduces ulcers 101,102
=B7 Improves peripheral vascular disease 103,104
=B7 Improves outcome in sepsis 105
=B7 Improves heart failure 106
=B7 Improves outcome of cancer treatment 107,108
=B7 Improve alzheimer's 109,110,111,112
=B7 Improves memory and cognitive functions 113,114,115
=B7 L-arginine has been shown to safe in the above studies as well as
others 100,116
To summarize, arginine by virtue of being a safe and natural Nitric
Oxide donor can be an
extremely significant factor in the treatment and reversal of most
major diseases.
4
The impact of the arginine in Ark1=99 on preventative healthcare and
anti-aging is
profound, not to mention that it is a safe and effective replacement
for the Viagra=AE type
drugs.
References
1=2E Fried R, Merrell WC. The Arginine Solution. New York, NY. Warner
Books, 1999.
2=2E Coffee, C J: Metabolism. Madison, Ct: Fence Creek Publishing,
1998.pp388-389
3=2E Catt KJ: Molecular Mechanisms of Hormone Action. In Endocrinology
and Metabolism, 3rd ed. Edited by Felig P,
Baxter JD, Frohman LA. New York, NY: McGraw-Hill, 1995, pp 138-139
4=2E Gerhard M, et al. Aging progressively impairs endothelium-dependent
vasodilation in forearm resistance vessels of
humans. Hypertension 1996 Apr;27(4):849-53
5=2E Toprakci M, et al. Age-associated changes in nitric oxide
metabolites, nitrite and nitrate. Int J Clin Lab Res
2000;30(2):83-5
6=2E Sakuma I, et al. Identification of arginine as a precursor of
endothelium-derived relaxing factor. Proc Natl Acad Sci
USA 1988 Nov;85(22):8664-7
7=2EVallance P, Moncada S. Nitric Oxide-from mediator to medicines. J R
Coll Physicians Lond 1994 May-Jun;28 (3):
209-219
8=2E Kam PC, Govender G. Nitric oxide: basic science and clinical
applications. Anaesthesia 1994 Jun;49(6): 515-21
9=2E Sinha G. Viagra: ups and downs. Popular Science 2000 July: page 35
10. Boger RH, Bode-Boger SM, Kienke S, et al. Dietary L-arginine
decreases myointimal cell proliferation and vascular
monocyte accumulation in cholesterol-fed rabbits.Atherosclerosis 1998
Jan;136(1) 67-77
11. Cheng JW, Balwin SN. L-Arginine in the management of
cardiovascular diseases. Ann Pharmacother 2001
Jun;35(6):755-64
12. Tentolouris C, Tousoulis D, et al. L-Arginine in coronary
atherosclerosis. Int J Cardiol 2000 Sep 15;75(2-3):123-8
13. Wang B, Ho HV, et al. Regression of atherosclerosis. Circulation
1999;99(9):1236-41
14. Boger RH, Bode-Boger SM, et al. Dietary L-arginine reduces the
progression of atherosclerosis in cholesterol fed
rabbits: comparison with lovastatin. Circulation 1997; 96(4):1282-90
15. Schuschke DA, Miller FN, Lominadze DG, Feldhoff RC. L-arginine
restores cholesterol-attenuated micro vascular
responses in the rat cremaster. Int J Micricirc Clin Exp 1994 Jul-Aug;
14(4): 204-11
16. Orlandi A, Marcellini M Spagnoli LG. Aging influences development
and progression of earl aortic atherosclerosis
lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasac Biol
2000 Apr;20
17. Chong PH, Bachenheimer BS. Current, New and future treatments in
dyslipidemia and atherosclerosis. Drugs
2000 Jul;60(1):55-93
18. Phivthong-ngam L, Bode-Boger SM, Boger RH, et al. Dietary L-
arginine normalizes endothelial induced vascular
contractions in cholesterol-fed rabbits. J Cardiovasc Pharmacol 1998
Aug;32(2): 300-7
19. Maxwell AJ, Anderson B Zapien MP, Cooke JP. Endothelial
dysfunction in hypercholesterolemia is reversed by:
nutritional product designed to enhance nitric oxide activity.
Cardiovasc Drugs Ther 2000 Jun;14(3):309-16
20. Clarkson P, Adams MR, Powe AJ, et al. Oral L-arginine improves
endothelial-dependent dilation in
hypercholesterolemic young adults. J Clin Invest 1996 April; 97(8):
1989-94
21. Cooke JP, Dzau J, Creager A. Endothelial dysfunction in
hypercholesterolemia is corrected by L-arginine. Basic
Res Cardiol 1991; 86 Suppl 2: 173-81
22. Fraser GE. Diet and coronary heart disease: beyond dietary fats
and low-density-lipoprotein cholesterol. Am J Clin
Nutr 1994 May;59(5 Suppl) 1117s-1142sand atherosclerosis. Drugs 2000
Jul;60(1):55-93
23. Quyyumi AA. Does acute improvement of endothelial dysfunction in
coronary arterydisease improve myocardial
ischemia? J Am Coll Cardiol 1998 Oct;32(4):904-11
24. Lerman A, Burnett JC Jr, Higano ST, et al. Long-term L-arginine
supplementation improves small vessel coronary
endothelial function in humans. Circulation 1998 Jun 2;97(21):1648-9
25. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of
supplemental oral L-arginine on exercise capacity
in patients with stable angina pectoris. Am J Cardiol 1997 Aug 1;
80(3):331-3
26. Desrois M, Sciaky M, Lan C, et al. L-arginine during long-term
ischemia: effects on cardiac function, energetic
metabolism and endothelial damage. J Heart Lung Transplant 2000 April;
19(4): 367-76
27. Quyyumi AA, Dakak N, Dodati JG, et al. Effect of L-arginine on
human coronary endothelium-dependent and
physiologic vasodilation, J AM Coll Cardiol 1997 Nov 1; 30(5):1220-7
28. Egashira K, et al. Effects of L-arginine supplementation on
endothelium-dependent coronary vasodilation in
patients with angina pectoris and normal coronary arteriograms.
Circulation 1996;94(2):130-4
29. Tentoluris C, et al. L-arginine in coronary atherosclerosis. Int J
Cardiol 2000 Sep15;75(2-3):123-8
5
30. Tretjakovs P, Kalnins U, Dabina I, et al. Plasma HDL-cholesterol
has an effect on nitric oxide production and
arachidonic production in the platelet membranes of coronary artery
disease patients without LDLhypercholesterolemia.
Med Sci Monitor 2000 May- Jun;6(3):507-11
31. Bode-Boger SM, Boger RH, Galland A, Tsikas D Frolich JC. L-
arginine induced vasodilatation in healthy humans:
pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 1998
Nov; 46(5): 489-97
32. Khedara A, Kawai Y Kayashita J Kato N. Feeding rats the nitric
oxide synthase inhibitor, L-N(omega) nitroarginine,
elevates serum triglycerides and cholesterol and lowers hepatic fatty
acid oxidation. J Nutr 1996 Oct;126(10):2563-
7
33. Boger RH, Bode-Boger SM, Theil W, et al. Restoring vascular nitric
oxide formation by L-arginine improves
symptoms of intermittent claudication in patients with Peripheral
arterial occlusive disease. J Am Col Cardiol 1998
Nov;32(5):1336-44
34. Maxwell AJ, Anderson BE Cooke JP. Nutritional therapy for
peripheral artery disease. Vasc Med 2000;5(1):11-19
35. Hiatt WR. New treatment options in intermittent claudication: the
US experience. Int J Clin Pract Suppl 2001
Apr;(119):20-27
36. Creager MA. Medical management of peripheral artery disease.
Cardiol Rev 2001 Jul-Aug;9(4):238-45
37. Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster HE. A
randomized double-blind study of oral L-arginine for
treatment of interstitial cystitis. J Urol 1999 Feb; 161(2):558-65
38. Cartledge JJ, Davies AM, Eardley I. A randomized double-blind
placebo-controlled crossover trial of the efficacy of
L-arginine in the treatment of interstitial cystitis. BJU Int 2000
Mar; 85(4):421-6
39. Sisic D, Francishetti A, Frolich ED. Prolonged L-arginine on
cardiovascular mass and myocardial hemodynamics
and collagen in aged spontaneously hypertensive and normal rats.
Hypertension 1999 Jan;33(1 Pt 2):451-5
40. Higashi Y, et al. Effects of L-arginine infusion on renal
hemodynamics in patients with mild hypertension.
Hypertension1995;25(4):898-902
41. Hishikawa K, et al. Role of L-arginine-nitric oxide pathway in
hypertension. J Hypertens 1993 Jun; 11(6):639-45
42. Dominiczak AF, Bohr DF. Nitric oxide and its' putative role in
hypertension. Hypertension 1995;25(6):1202-11
43. Nakaki T, et al. L-arginine induced hypotension. Lancet 1990Oct
20; 336(8721):1016-7
44. Braga M, Gianotti L Raedelli G, et al. Perioperative
immunonutrition in patients undergoing cancer surgery: results
of a randomized double-blind phase 3 trial. Arch Surg 1999 Apr;134(4):
428-33
45. Ghigo E, Aimaretti G, Cornelli G, et al. Diagnosis of GH
deficiency in adults. Growth Hormone IGF Res 1998 Feb;8
Suppl A:55-8
46. Wideman L Weltman JY, Patrie JY, et al. Synergy of L-arginine and
GHRP-2 stimulation of growth hormone in men
and women: modulation by exercise. Am J Physiol Regul Integr Comp
Physiol 2000 Oct;279(4):R1467-77
47. Gianotti L,